Answers are grounded in this paper and cite their sources.
Cross-sectional study finds elevated odds of cognitive impairment and sarcopenia risk in adults with silicosis, indicating a need for routine functional screening.
Silicosis, an incurable occupational lung disease caused by inhalation of crystalline silica dust, may be associated with cognitive impairment and sarcopenia risk, both linked to disability; however, silicosis-specific evidence remains limited. This cross-sectional study included 264 individuals with silicosis and 270 age- and sex-matched community controls (total n = 534, all Chinese adults aged ≥ 50 years). Cognitive function, disability (WHODAS 2.0), sarcopenia risk (SARC-F), social support, coping strategies, handgrip strength, skeletal muscle mass, and six-minute walk distance were assessed. Data were analyzed using chi-square tests, logistic and multiple linear regression. Individuals with silicosis had significantly higher disability scores (mean 33.77 vs. 23.05, p < 0.001). Prevalence of cognitive impairment was 49.6% in the silicosis group versus 8.8% in controls (adjusted odds ratio [aOR] 3.77, 95% CI 1.96–7.27). Prevalence of sarcopenia risk was 14.8% versus 2.2% (aOR 4.07, 95% CI 1.40–11.81 after sociodemographic and clinical adjustment). Cognitive function and sarcopenia risk, muscle strength and mass, together with covariates, explained 38% of the variance in disability scores (adjusted R²=0.38, p < 0.001). Silicosis is independently associated with increased odds of cognitive impairment and sarcopenia risk; both are associated with greater disability. Due to the cross-sectional design, causality cannot be inferred. Routine screening for these conditions in silicosis care warrants further evaluation.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: